Pharmacological rationale for the use of somatostatin and analogues in portal hypertension.
about
Octreotide attenuates liver fibrosis by inhibiting hepatic heme oxygenase-1 expression.Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.A somatostatin analog improves tilt table tolerance by decreasing splanchnic vascular conductanceA Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or HigherDoppler waveform study as indicator of change of portal pressure after administration of octreotide.Emerging therapies for portal hypertension in cirrhosis.Use of portal pressure studies in the management of variceal haemorrhage.Association between a polymorphic poly-T repeat sequence in the promoter of the somatostatin gene and hypertension.Construction of an expression vector for production and purification of human somatostatin in Escherichia coli.
P2860
Q34540787-2FFAB6DE-EAFB-491C-BCF3-3FC0D91ECCEDQ35651447-4315F9B5-F349-40CB-9EC9-65E7E84E3CC7Q35994705-45B5A7EF-3252-416B-A811-5843E7921C4FQ37198606-88B8010D-D29B-4C86-8E1B-F8D3E86EF9F8Q37244103-CB90EBC0-D158-4E0B-98C8-1CE56A0906BDQ38826464-D211D0FF-F9AC-495C-B84A-921223F75214Q42240290-E0FD7C05-2523-48B4-8E77-BC1308175201Q48693540-8E3FA01D-C896-40C5-854B-1B91A5AA6AA1Q51022165-C80FDD68-012F-4241-9B3E-E0BACCE93F23
P2860
Pharmacological rationale for the use of somatostatin and analogues in portal hypertension.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacological rationale for ...... logues in portal hypertension.
@ast
Pharmacological rationale for ...... logues in portal hypertension.
@en
type
label
Pharmacological rationale for ...... logues in portal hypertension.
@ast
Pharmacological rationale for ...... logues in portal hypertension.
@en
prefLabel
Pharmacological rationale for ...... logues in portal hypertension.
@ast
Pharmacological rationale for ...... logues in portal hypertension.
@en
P2860
P1476
Pharmacological rationale for ...... logues in portal hypertension.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2036.2003.01657.X
P407
P577
2003-08-01T00:00:00Z